免疫浸润-话题@MedSci

#免疫浸润#

8篇内容 | 750人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2200157, encodeId=35f6220015ef1, content=<a href='/topic/show?id=d5131100e823' target=_blank style='color:#2F92EE;'>#急性髓系白血病（AML）#</a> <a href='/topic/show?id=f048290e85c' target=_blank style='color:#2F92EE;'>#免疫浸润#</a> <a href='/topic/show?id=9bd4113e2476' target=_blank style='color:#2F92EE;'>#KIR2DL#</a>, objectTitle=J Cell Mol Med：KIR2DL家族作为预后生物标志物，与急性髓系白血病的免疫浸润相关, objectType=article, longId=823098, objectId=4c03823098c6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221201/1669967708187_4754896.jpeg, objectUrl=/article/show_article.do?id=4c03823098c6, replyNumber=0, likeNumber=5, createdTime=2024-04-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4c03823098c6, moduleTitle=J Cell Mol Med：KIR2DL家族作为预后生物标志物，与急性髓系白血病的免疫浸润相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c03823098c6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1557312, encodeId=5a27155e3127f, content=<a href='/topic/show?id=f048290e85c' target=_blank style='color:#2F92EE;'>#免疫浸润#</a>, objectTitle=Dig Dis Sci: 羟基类固醇17-β脱氢酶6（HSD17β6）是一种肝细胞癌的免疫浸润相关预后性生物标志物, objectType=article, longId=206314, objectId=59192063146e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59192063146e, replyNumber=0, likeNumber=40, createdTime=2021-01-29, rootId=0, userName=cenghis, userId=769d14903231, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59192063146e, moduleTitle=Dig Dis Sci: 羟基类固醇17-β脱氢酶6（HSD17β6）是一种肝细胞癌的免疫浸润相关预后性生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59192063146e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1557311, encodeId=c7b8155e311bc, content=<a href='/topic/show?id=f048290e85c' target=_blank style='color:#2F92EE;'>#免疫浸润#</a>, objectTitle=Nat Med：透明细胞肾细胞肿瘤中体细胞变异和免疫浸润互作调控对PD-1阻断的响应, objectType=article, longId=195038, objectId=f5ec19503892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5ec19503892, replyNumber=0, likeNumber=34, createdTime=2020-06-02, rootId=0, userName=cenghis, userId=769d14903231, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5ec19503892, moduleTitle=Nat Med：透明细胞肾细胞肿瘤中体细胞变异和免疫浸润互作调控对PD-1阻断的响应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5ec19503892)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1557310, encodeId=1c00155e31011, content=<a href='/topic/show?id=f048290e85c' target=_blank style='color:#2F92EE;'>#免疫浸润#</a>, objectTitle=Eur Urol：分子亚型和免疫浸润对肌层浸润性膀胱癌新辅助Pembrolizumab治疗的病理响应和结果影响, objectType=article, longId=190995, objectId=3a86190995c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a86190995c8, replyNumber=0, likeNumber=37, createdTime=2020-03-29, rootId=0, userName=cenghis, userId=769d14903231, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a86190995c8, moduleTitle=Eur Urol：分子亚型和免疫浸润对肌层浸润性膀胱癌新辅助Pembrolizumab治疗的病理响应和结果影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a86190995c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1557309, encodeId=0e26155e309f6, content=<a href='/topic/show?id=f048290e85c' target=_blank style='color:#2F92EE;'>#免疫浸润#</a>, objectTitle=Oncogene：BRF1能够促进前列腺致瘤和干扰免疫浸润, objectType=article, longId=183913, objectId=3170183913ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3170183913ce, replyNumber=0, likeNumber=26, createdTime=2019-12-03, rootId=0, userName=cenghis, userId=769d14903231, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3170183913ce, moduleTitle=Oncogene：BRF1能够促进前列腺致瘤和干扰免疫浸润, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3170183913ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1557308, encodeId=561d155e308b7, content=<a href='/topic/show?id=f048290e85c' target=_blank style='color:#2F92EE;'>#免疫浸润#</a>, objectTitle=Prostate Cancer P D：SPINK1表达在非裔美国人前列腺中富集并且与术后免疫浸润或者肿瘤结果无关, objectType=article, longId=162799, objectId=0967162e9971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0967162e9971, replyNumber=0, likeNumber=31, createdTime=2019-03-25, rootId=0, userName=cenghis, userId=769d14903231, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0967162e9971, moduleTitle=Prostate Cancer P D：SPINK1表达在非裔美国人前列腺中富集并且与术后免疫浸润或者肿瘤结果无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0967162e9971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1557307, encodeId=a4bc155e3076d, content=<a href='/topic/show?id=f048290e85c' target=_blank style='color:#2F92EE;'>#免疫浸润#</a>, objectTitle=Clin Cancer Res：结直肠癌有前途的疗效预测和预后标志物：SMAD4缺失与复发、缺少免疫浸润和化疗耐药相关, objectType=article, longId=158432, objectId=5b21158432fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b21158432fa, replyNumber=0, likeNumber=37, createdTime=2019-01-20, rootId=0, userName=cenghis, userId=769d14903231, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b21158432fa, moduleTitle=Clin Cancer Res：结直肠癌有前途的疗效预测和预后标志物：SMAD4缺失与复发、缺少免疫浸润和化疗耐药相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b21158432fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1557306, encodeId=9579155e30678, content=<a href='/topic/show?id=f048290e85c' target=_blank style='color:#2F92EE;'>#免疫浸润#</a>, objectTitle=JAMA：三阴性乳腺癌免疫浸润与何相关？, objectType=article, longId=108084, objectId=e15f1080847d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e15f1080847d, replyNumber=0, likeNumber=31, createdTime=2017-08-10, rootId=0, userName=cenghis, userId=769d14903231, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e15f1080847d, moduleTitle=JAMA：三阴性乳腺癌免疫浸润与何相关？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e15f1080847d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1557305, encodeId=bd0d155e30521, content=<a href='/topic/show?id=f048290e85c' target=_blank style='color:#2F92EE;'>#免疫浸润#</a>, objectTitle=Oncotarget：免疫浸润检测有利于预测直肠癌术前放化疗反应性, objectType=article, longId=107658, objectId=f40c10e65825, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f40c10e65825, replyNumber=0, likeNumber=42, createdTime=2017-08-05, rootId=0, userName=cenghis, userId=769d14903231, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f40c10e65825, moduleTitle=Oncotarget：免疫浸润检测有利于预测直肠癌术前放化疗反应性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f40c10e65825)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫浸润

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓系白血病（AML）# #免疫浸润# #KIR2DL#

J Cell Mol Med：KIR2DL家族作为预后生物标志物，与急性髓系白血病的免疫浸润相关

2024-04-24发表于上海

cenghis (审核中...)

前往app查看评论内容

#免疫浸润#

Dig Dis Sci: 羟基类固醇17-β脱氢酶6（HSD17β6）是一种肝细胞癌的免疫浸润相关预后性生物标志物

2021-01-29

cenghis (审核中...)

前往app查看评论内容

#免疫浸润#

Nat Med：透明细胞肾细胞肿瘤中体细胞变异和免疫浸润互作调控对PD-1阻断的响应

2020-06-02

cenghis (审核中...)

前往app查看评论内容

#免疫浸润#

Eur Urol：分子亚型和免疫浸润对肌层浸润性膀胱癌新辅助Pembrolizumab治疗的病理响应和结果影响

2020-03-29

cenghis (审核中...)

前往app查看评论内容

#免疫浸润#

Oncogene：BRF1能够促进前列腺致瘤和干扰免疫浸润

2019-12-03

cenghis (审核中...)

前往app查看评论内容

#免疫浸润#

Prostate Cancer P D：SPINK1表达在非裔美国人前列腺中富集并且与术后免疫浸润或者肿瘤结果无关

2019-03-25

cenghis (审核中...)

前往app查看评论内容

#免疫浸润#

Clin Cancer Res：结直肠癌有前途的疗效预测和预后标志物：SMAD4缺失与复发、缺少免疫浸润和化疗耐药相关

2019-01-20

cenghis (审核中...)

前往app查看评论内容

#免疫浸润#

JAMA：三阴性乳腺癌免疫浸润与何相关？

2017-08-10

cenghis (审核中...)

前往app查看评论内容

#免疫浸润#

Oncotarget：免疫浸润检测有利于预测直肠癌术前放化疗反应性

2017-08-05

科室
- - 订阅+
  - 更多科室
工具
服务